`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`ARGENTUM PHARMACEUTICALS LLC.,
`PETITIONER,
`
`v.
`
`COSMO TECHNOLOGIES LIMITED
`Patent Owner.
`
`___________________
`
`Case IPR2018-00080
`U.S. Patent No. 9,320,716
`___________________
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICE
`PURSUANT TO 37 C.F.R. 42.8
`
`
`
`
`
`
`Mail Stop: PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`10028290
`
`
`- 1 -
`
`
`
`
`
`IPR2018-00080
`Patent No. 9,320,716
`
`
`
`Pursuant to 37 C.F.R. 42.8, Patent Owner Cosmo Technologies Limited
`
`hereby submits the following Notice.
`
`I.
`
`Real Party-In-Interest
`
`The real party-in-interest are Cosmo Technologies Limited, Cosmo
`
`Pharmaceuticals NV, Valeant Pharmaceuticals International, and Valeant
`
`Pharmaceuticals Ireland.
`
`II. Related Matters
`
`The following related U.S. Patent No. 9,320,716 patent family members exist:
`
`U.S. Patent No. 7,410,651; U.S. Patent No. 8,784,888; U.S. Patent No. RE 43,799,
`
`formerly U.S. Patent No. 8,029,823; U.S. Patent No. 8,293,273; U.S. Patent No.
`
`7,431,943; U.S. Patent No. 9,532,954; U.S. Patent No. 7,410,652; and U.S. App.
`
`No. 15/369,296.
`
`The ’716 patent is currently or has been the subject of the following
`
`litigations: Cosmo Technologies Limited et al. v. Mylan Pharmaceuticals Inc., 16-
`
`cv-00152 (D. Del.); Cosmo Technologies Ltd. et al. v. Lupin Ltd. et al, 15-cv-00669
`
`(D. Del.); Cosmo Technologies Limited et al. v. Alvogen Pine Brook, Inc., 15-cv-
`
`00193 (D. Del.); Cosmo Technologies Ltd et al. v Actavis Laboratories FL, Inc., 15-
`
`cv-00164 (D. Del.); Cosmo Technologies Limited et al. v. Par Pharmaceutical, Inc.,
`
`15-cv-00116 (D. Del.).
`
`10028290
`
`
`- 2 -
`
`
`
`
`
`IPR2018-00080
`Patent No. 9,320,716
`
`This Inter Partes Review is related to IPR2017-01035 for U.S. Patent
`
`No. 9,320,716.
`
`III. Lead And Back-Up Counsel
`
`LEAD COUNSEL
`Gary N. Frischling (Reg. No. 35,515)
`IRELL & MANELLA LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, California 90067
`Telephone: (310) 277-7597
`Facsimile: (310) 203-7199
`gfrischling@irell.com
`
`
`BACK-UP COUNSEL
`Yite John Lu (Reg. No. 63,158)
`IRELL & MANELLA LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, California 90067
`Telephone: (310) 277-7556
`Facsimile: (310) 556-5240
`yjlu@irell.com
`
`
`IV. Service Information
`
`Please address all correspondence to the lead and back-up counsel as shown
`
`above.
`
`Dated: November 13, 2017
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`/s/ Gary N. Frischling
`Gary N. Frischling
`Reg. No. 35,515
`
`Irell & Manella LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, CA 90067-4276
`Telephone: (310) 277-1010
`Fax: (310) 203-7199
`
`Attorneys for Patent Owner
`
`10028290
`
`
`- 3 -
`
`
`
`
`
`IPR2018-00080
`Patent No. 9,320,716
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`Pursuant to 37 C.F.R. 42.6, the undersigned certifies that on November 13,
`
`2017, a copy of the foregoing document and Patent Owner’s Power of Attorney
`
`were served by electronic mail upon the following:
`
`Tyler C. Liu
`Reg. No. 72,126
`Argentum Pharmaceuticals LLC
`202-749-8605
`TLiu@agpharm.com
`
`Michael Houston
`Reg. No. 58,486
`FOLEY & LARDNER LLP
`321 North Clark Street, Suite 2800
`Chicago, Illinois 60654
`312-832-4500
`mhouston@foley.com
`
`Joseph P. Meara
`Reg. No. 44,932
`James McParland, Ph.D.
`Reg. 69,440
`FOLEY & LARDNER LLP
`150 East Gilman St.
`Madison, WI 53703-1482
`608-258-4303
`jmeara@foley.com
`
`Kevin Laurence
`Reg. No. 38,219
`LAURENCE & PHILLIPS IP
`LAW LLP
`klaurence@lpiplaw.com;
`
`
`10028290
`
`
`- 4 -
`
`
`
`
`
`IPR2018-00080
`Patent No. 9,320,716
`
`Matthew Phillips
`Reg. No. 43,403
`LAURENCE & PHILLIPS IP
`LAW LLP
`mphillips@lpiplaw.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Susan Langworthy
`
`
`
`
`
`10028290
`
`
`- 5 -
`
`
`
`